Oxidative Stress in Brain in Amnestic Mild Cognitive Impairment

Area of Science:

• Neuroscience
• Biochemistry
• Gerontology

Background:

• Amnestic Mild Cognitive Impairment (MCI) is the earliest clinical stage of Alzheimer's Disease (AD).
• MCI is characterized by memory impairment but preserved daily living activities.
• Oxidative stress and subsequent cellular damage are evident even in MCI.

Purpose of the Study:

• To review the role of oxidative stress in Amnestic Mild Cognitive Impairment.
• To explain how oxidative stress contributes to neuronal loss in early AD.
• To discuss potential therapeutic strategies to mitigate MCI progression to AD.

Main Methods:

• Literature review of studies on oxidative stress in MCI and AD.
• Analysis of biochemical mechanisms linking oxidative stress to neuronal damage.
• Synthesis of current therapeutic approaches targeting oxidative stress.

Main Results:

• Oxidative stress significantly damages key proteins and lipids in MCI.
• This damage is a key factor in early neuronal loss observed in AD.
• Evidence suggests a strong correlation between oxidative stress markers and MCI severity.

Conclusions:

• Oxidative stress is a critical factor in the pathogenesis of MCI and progression to AD.
• Targeting oxidative stress pathways presents a promising therapeutic avenue.
• Early intervention strategies focusing on reducing oxidative stress may slow AD progression.